Deloitte will stop covering GLP-1 medications prescribed for weight loss under its US employee health plans from January 2027. The company will also raise deductibles and maximum out-of-pocket…
Deloitte will stop covering GLP-1 medications prescribed for weight loss under its US employee health plans from January 2027. The company will also raise deductibles and maximum out-of-pocket payments under most medical plans, adding to healthcare expenses for its workforce. These changes apply to all client facing accountants, consultants, and specialists at Deloitte, including those in Core, Domain, and Enterprise employees. There are 181,000 employees of Deloitte in the US.
According to the guidelines of the employee benefits, published in Business Insider, the insurance coverage of GLP-1 drugs will not be affected in case of their use for treatment of diabetes and any other diseases except for weight loss. Deloitte said the decision was influenced by growing pressure on health-care spending. Its program description described the new plan as "the hard trade-offs of today's cost environment". It also demanded ‘shared responsibility’ in the domains where the company cannot cover increasing costs alone anymore.
The firm has provided an alternative option for its employees seeking help with weight loss. The partnership between the firm and eMed entails the provision of a virtual program with coaching. Deloitte also covers USD 125 of each qualifying prescription. Rising Healthcare Costs Push Employers The decision reflects a wider shift among US employers reviewing expensive medical benefits. GLP-1 medicines have attracted better demand for weight management, increasing pressure on company-sponsored insurance plans.
A 2026 KFF survey found that average annual premiums paid by employees with family health coverage rose 9% to USD 7,471. Total family premiums, including employer contributions, reached USD 28,303. According to Aon, the use of GLP-1 in 2025 went up by 75%. The survey further showed that 39% of organizations planned to cut back on their coverage in 2026. Deloitte is among the organizations providing additional benefits including better long-term disability insurance as well as free eye exams per year under the vision discount program.
Similar measures have been taken by other companies. PwC and Starbucks are among organizations cutting back on insurance coverage for weight loss using GLP-1.
This is a source-linked briefing. Read the original report from Industry Wired .